Hypomagnesemia and clinical benefits of anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer: a systematic review and meta-analysis

Hypomagnesemia is a recognized side-effect of cetuximab- or panitumumab-based chemotherapy for metastatic colorectal cancer (mCRC). The clinical relevance of hypomagnesemia is under debate. Thus, a systematic review and meta-analysis of retrospective studies and randomized clinical trials (RCTs) com...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng-Chiao, Wu, Chun-Feng, Chen, Chun-Wei, Shi, Chung-Sheng, Huang, Wen-Shih, Kuan, Feng-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794997/
https://www.ncbi.nlm.nih.gov/pubmed/29391418
http://dx.doi.org/10.1038/s41598-018-19835-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794997/
https://www.ncbi.nlm.nih.gov/pubmed/29391418
http://dx.doi.org/10.1038/s41598-018-19835-8

Ejemplares similares